Prognostic significance of pathological and biological factors in hepatocellular carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 6, 1998, Pages 666-670

  Ng, Irene O L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Biology; Hepatocellular carcinoma; Pathology; Prognosis

Indexed keywords

CYCLINE; ESTROGEN RECEPTOR; HORMONE RECEPTOR; KI 67 ANTIGEN; PROTEIN P53;

CANCER CELL; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; ENCAPSULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEX DIFFERENCE; TUMOR DIFFERENTIATION; TUMOR RECURRENCE;

EID: 7344258851     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00709.x     Document Type: Review

References (44)

1. Lai ECS, Ng IOL, Ng MMT et al. Long-term results of resection for large hepatocellular carcinoma: a multivariate analysis of clinicopathological features. Hepatology 1990; 11: 815-18.
2. Sugioka A, Tsuzuki T, Kanai T. Postresection prognosis of patients with hepatocellular carcinoma. Surgery 1993; 113: 612-18.
3. Nagasue N, Uchida M, Makino Y et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993; 105: 488-94.
4. Lai ECS, Ng IOL,You KT et al. Hepatic resection for small hepatocellular carcinoma: the Queen Mary Hospital experience. World J. Surg. 1991; 15: 654-9.
5. Ng IOL, Lai ECS, Fan ST, Ng MMT, So MKP. Prognostic significance of pathologic features of hepatocellular carcinoma - a multivariate analysis of 278 patients. Cancer 1995; 76: 2443-8.
6. Matsumata T, Kanematsu T, Takenaka K, Yoshida Y, Nishizaki T, Sugimachi K. Patterns of intrahepatic recurrence after curative resection of hepatocellular carcinoma. Hepatology 1989; 9: 457-60.
7. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann. Surg. 1991; 214: 114-17.
8. Okuda K, Musha H, Nakajima Y et al. Clinicopathologic features of encapsulated hepatocellular carcinoma. A study of 26 cases. Cancer 1977; 40: 1240-5.
9. Kemeny F, Vadrot J, Wu A et al. Morphological and histological features of resected hepatocellular carcinoma in cirrhotic patients in the West. Hepatology 1989; 9: 253-7.
10. Ng IOL, Lai ECS, Ng MMT, Fan ST. Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer 1992; 70: 45-9.
11. Nagao T, Inoue S, Goto S et al. Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann. Surg. 1987; 205: 33-40.
12. Franco D, Capussotti L, Smadja C et al. Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis. Gastroenterology 1990; 98: 733-8.
13. Wasaka K, Sakurai M, Kuroda C et al. Effect of transcatheter arterial embolization on the boundary architecture of hepatocellular carcinoma. Cancer 1990; 65: 913-19.
14. Lai ECS, You KY, Ng IOL, Shek TWH. The pathological basis of resection margin for hepatocellular carcinoma. World J. Surg. 1993; 17: 786-91.
15. Yamamoto J, Kosuge T, Takayama T et al. Recurrence of hepatocellular carcinoma after surgery. Br. J. Surg. 1996; 83: 1219-22.
16. Suehiro T, Matsumata T, Itasaka H, Yamamoto K, Kawahara N, Sugimachi K. Clinicopathologic features and prognosis of resected hepatocellular carcinomas of varied sizes with special reference to proliferating cell nuclear antigen. Cancer 1995; 76: 399-405.
17. Ng IOL, Lai ECS, Fan ST, Ng M, Chan ASY, So MKP. Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma. Cancer 1994; 73: 2268-74.
18. Adachi E, Hashimoto H, Tsuneyoshi M. Proliferating cell nuclear antigen in hepatocellular carcinoma and small cell liver dysplasia. Cancer 1994; 72: 2902-9.
19. Cattoretti G, Becker MHG, Key G et al. Monoclonal antibodies against recombinant parts of the Ki67 antigen (MIB1 and MIB3) detect proliferating cells in microwave processed formalin-fixed paraffin sections. J. Pathol. 1992; 168: 357-64.
20. Ng IOL, Na J, Lai ECS, Fan ST, Ng M. Expression of Ki67 antigen in hepatocellular carcinoma using monoclonal antibody MIB1 - a comparison with proliferating cell nuclear antigen. Am. J. Clin. Pathol. 1995; 104: 313-18.
21. Shimizu K, Izumi R, Ii T et al. Prognostic significance of nucleolar organizer regions in hepatocellular carcinoma. Hepatology 1995; 21: 393-7.
22. Ezaki T, Kanematsu T, Okamura T et al. DNA analysis of hepatocellular carcinoma and clinicopathologic implications. Cancer 1988; 61: 106-9.
23. Ishizu H. Flow cytometric analysis of the nuclear DNA content of hepatocellular carcinoma. Jpn. J. Surg. 1989; 19: 662-73.
24. Fujimoto J, Okamoto E, Yamanaka N, Toyasaka A, Mitsunobu M. Flow cytometric DNA analysis of hepatocellular carcinoma. Cancer 1991; 67: 939-44.
25. Chen MF, Hwang TL, Tsao KC, Sun CF, Chen TJ. Flow cytometric DNA analysis of hepatocellular carcinoma: preliminary report. Surgery 1991; 109: 455-8.
26. Jwo SC, Chiu JH, Chau GY, Loong CC, Lui WY. Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology 1992; 16: 1367-71.
27. Chiu JH, Kao HL, Wu LH, Chang HM, Lui WY. Prediction of relapse or survival after resection in human hepatomas by DNA flow cytometry. J. Clin. Invest. 1992; 89: 539-45.
28. McEntree GP, Batts KA, Katzmann JA, Ilstrup DM, Nagorney DM. Relationship of nuclear DNA content to clinical and pathologic findings in patients with primary hepatic malignancy. Surgery 1992; 111: 376-9.
29. Nagasue N, Yamanoi A, Takemoto Y et al. Comparison between diploid and aneuploid hepatocellular carcinomas: a flow cytometric study. Br. J. Surg. 1992; 79: 667-70.
30. Ng IOL, Lai ECS, Ho JCW, Cheung LKN, Ng MMT, So MKP. Flow cytometric analysis of DNA ploidy in hepatocellular carcinoma. Am. J. Clin. Pathol. 1994; 102: 80-6.
31. Okada S, Ishii H, Nose H et al. Intratumoral DNA heterogeneity of small hepatocellular carcinoma. Cancer 1995; 75: 444-50.
32. Challen C, Lunec J, Warren W, Collier J, Bassendine MF. Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain. Hepatology 1992; 16: 1362-6.
33. Soini Y, Virkajarvi N, Lehto VP, Paakko P. Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival. Br. J. Cancer 1996; 73: 1025-30.
34. Ng IOL, Srivastava G, Chung LP, Tsang SWY, Ng MMT. Overexpression and point mutation of p53 tumor suppressor gene in hepatocellular carcinomas in Hong Kong Chinese people. Cancer 1994; 74: 30-7.
35. Hsia CC, Kleiner DE Jr, Axiotis CA et al. Mutations of p53 gene in hepatocellular carcinoma: Roles of hepatitis B virus and aflatoxin contamination in the diet. J. Natl Cancer Inst. 1992; 84: 1638-41.
36. Hsu HC, Tseng HJ, Lai PL, Lee PH, Peng SH. Expression of p53 gene in 184 unifocal hepatocellular carcinoma: association with tumor growth and invasiveness. Cancer Res. 1993; 53: 4691-4.
37. Ng IOL, Lai ECS, Chan ASY, So MKP. Overexpression of p53 in hepatocellular carcinomas - a clinicopathological and prognostic correlation. J. Gastroenterol. Hepatol. 1995; 10: 250-5.
38. Nagasue N, Kohno H, Chang YC et al. Clinicopathologic comparisons between estrogen receptor-positive and -negative hepatocellular carcinoma. Ann. Surg. 1990; 212: 150-4.
39. Ng IOL, Ng M, Fan ST. Better survival in women with resected hepatocellular carcinoma is not related to tumour cell proliferation nor tumour expression of estrogen and progesterone receptors. Am. J. Gastroenterol. 1997; 92: 1355-8.
40. Boix L, Bruix J, Castells A et al. Sex hormone receptors in hepatocellular carcinoma - Is there a rationale for hormonal treatment? J. Hepatol. 1993; 17: 187-91.
41. Nagasue N, Yu L, Yukaya H, Kohno H, Nakamura T. Androgen and oestrogen receptors in hepatocellular carcinoma and surrounding liver parenchyma: impact on intrahepatic recurrence after hepatic resection. Br. J. Surg. 1995; 82: 542-7.
42. Boix L, Castells A, Bruix J et al. Androgen receptors in hepatocellular carcinoma and surrounding liver: relationship with tumor size and recurrence rate after surgical resection. J. Hepatol. 1995; 22: 616-22.
43. Cong WM, Wu MC, Zhang XH, Chen H, Yuan JY. Primary hepatocellular carcinoma in women of Mainland China. Cancer 1993; 71: 2941-5.
44. Ng IOL, Ng M, Lai ECS, Fan ST. Better survival in female patients with hepatocellular carcinoma - possible causes from a pathologic approach. Cancer 1995; 75: 18-22.